Emergence of oseltamivir resistance: control and management of influenza before, during and after the pandemic
- PMID: 23675925
- DOI: 10.2174/18715265112129990006
Emergence of oseltamivir resistance: control and management of influenza before, during and after the pandemic
Abstract
Neuraminidase inhibitors (NAIs), such as oseltamivir and zanamivir, are the medicines of choice against influenza A or B. Oseltamivir resistance can be conferred by a single point missense mutation from histidine to tyrosine at position 275 (H275Y) of the neuraminidase gene. Oseltamivir resistance in seasonal influenza A/H1N1 strains rose markedly during the 2007-2008 season. Furthermore, oseltamivir resistant (OsR) strains of pandemic influenza A/H1N1 2009 (influenza A(H1N1)pdm09) have been increasingly isolated, although the majority remain sensitive. These OsR strains retain virulence, replicative fitness and transmissibility from person to person, with outbreaks reported. Treatment options in those at risk of severe or complicated disease are limited to zanamivir which is only licenced in those over the age of 5 years; of further concern, strains demonstrating low level resistance to both oseltamivir and zanamivir have been reported. Strategies to reduce emergence of resistant strains, such as higher dose oseltamivir regimens, need further examination.
Similar articles
-
[Role of neuraminidase inhibitors for the treatment of influenza A virus infections].Pathol Biol (Paris). 2010 Apr;58(2):e69-78. doi: 10.1016/j.patbio.2010.01.011. Epub 2010 Mar 19. Pathol Biol (Paris). 2010. PMID: 20303677 Review. French.
-
Molecular pathway of influenza pan-neuraminidase inhibitor resistance in an immunocompromised patient.Antivir Ther. 2019;24(8):581-587. doi: 10.3851/IMP3344. Antivir Ther. 2019. PMID: 32031540
-
Neuraminidase inhibitor susceptibility profile of pandemic and seasonal influenza viruses during the 2009-2010 and 2010-2011 influenza seasons in Japan.Antiviral Res. 2013 Sep;99(3):261-9. doi: 10.1016/j.antiviral.2013.06.003. Epub 2013 Jun 17. Antiviral Res. 2013. PMID: 23791870
-
Influenza A(H1N1)pdm09 resistance and cross-decreased susceptibility to oseltamivir and zanamivir antiviral drugs.J Med Virol. 2015 Jan;87(1):45-56. doi: 10.1002/jmv.23986. Epub 2014 Jul 21. J Med Virol. 2015. PMID: 25042157
-
Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza.Expert Rev Anti Infect Ther. 2011 Oct;9(10):851-7. doi: 10.1586/eri.11.112. Expert Rev Anti Infect Ther. 2011. PMID: 21973296 Review.
Cited by
-
High-Efficiency Capture of Drug Resistant-Influenza Virus by Live Imaging of Sialidase Activity.PLoS One. 2016 May 27;11(5):e0156400. doi: 10.1371/journal.pone.0156400. eCollection 2016. PLoS One. 2016. PMID: 27232333 Free PMC article.
-
Oseltamivir-resistant influenza A(H1N1)pdm2009 strains found in Brazil are endowed with permissive mutations, which compensate the loss of fitness imposed by antiviral resistance.Mem Inst Oswaldo Cruz. 2015 Feb;110(1):101-5. doi: 10.1590/0074-02760140330. Epub 2015 Feb 27. Mem Inst Oswaldo Cruz. 2015. PMID: 25742269 Free PMC article.
-
Benefits of using heterologous polyclonal antibodies and potential applications to new and undertreated infectious pathogens.Vaccine. 2016 Feb 24;34(9):1152-61. doi: 10.1016/j.vaccine.2016.01.016. Epub 2016 Jan 20. Vaccine. 2016. PMID: 26802604 Free PMC article. Review.
-
An ultrasensitive, rapid and portable method for screening oseltamivir-resistant virus based on CRISPR/Cas12a combined with immunochromatographic strips.Acta Biochim Biophys Sin (Shanghai). 2022 Nov 25;54(11):1630-1636. doi: 10.3724/abbs.2022163. Acta Biochim Biophys Sin (Shanghai). 2022. PMID: 36604145 Free PMC article.
-
Diagnostic accuracy of a rapid RT-PCR assay for point-of-care detection of influenza A/B virus at emergency department admission: A prospective evaluation during the 2017/2018 influenza season.PLoS One. 2019 May 7;14(5):e0216308. doi: 10.1371/journal.pone.0216308. eCollection 2019. PLoS One. 2019. PMID: 31063477 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical